Related Articles
Relationship between expression of plasminogen activator system and metastatic ability in human cancers
HER-2/NEU AND FIBRINOLYTIC FACTORS IN HUMAN BREAST-CANCER
MEDROXYPROGESTERONE ACETATE (MPA) INCREASES PAI-1 SECRETION FROM HUVEC AND ELEVATES THE PLASMA-LEVELS OF PAI-I IN-VIVO
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: An EORTC Receptor and Biomarker Group collaboration
Role of urokinase-type plasminogen activator and inhibitory effect of protease inhibitor in invasion and metastasis of pancreatic cancer